Aromando Andrew
- SEC CIK
- 0001976455
In the past year, 1 open-market purchase filing worth $25.5K and no sales.
Current role at each company
- ONCY Oncolytics Biotech IncChief Business Officeras of Jun 3, 2026
- AMAM Ambrx Biopharma, Inc.Chief Operating Officeras of Mar 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $25.5K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$25.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Aromando Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ONCY Oncolytics Biotech Inc
Chief Business Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 (view filing) | Feb 11 | 2 days | Aromando AndrewChief Business Officer | PPurchase | +29.6K | $0.86 | +$25.5K | +116.1%55.1K after |